Navigation Links
New data from NIH lab confirms protocol to reverse type 1 diabetes in mice

New data published in the Nov. 24 issue of Science supports the protocol to reverse type 1 diabetes in mice and there is proof now that adult precursor cells// from the spleen can add to the renewal of beta cells. In 2001 and 2003, researchers at Massachusetts General Hospital (MGH) showed the benefits of a procedure to turnaround type 1 diabetes in diabetic mice.

Three studies from other institutions published in the March 24, 2006 issue of Science confirmed that the MGH-developed protocol can reverse the underlying disease but were inconclusive on the role of spleen cells in the recovery of insulin-producing pancreatic islets. The new data from a study performed at the National Institutes of Health (NIH), published as a technical comment, provides additional confirmation of the ability to reverse type 1 diabetes and on the role of the spleen cells in islet regeneration.

"This data from the NIH and the earlier studies have added significantly to the understanding of how diabetes may be reversed," says Denise Faustman, MD, PhD, director of the Immunobiology Laboratory at Massachusetts General Hospital, primary author of the 2001 and 2003 studies and co-corresponding author of the current report. "It is still early, but it appears that there are multiple potential sources for regenerating islets. As a research community we should pursue all avenues. We're excited to see what will happen in humans."

In the 2001 and 2003 studies, Faustman and colleagues treated end-stage nonobese diabetic (NOD) mice with Freund's complete adjuvant, a substance that suppresses the activity of the immune cells that destroy islets in type 1 diabetes. They also introduced donor spleen cells to retrain the immune system not to attack islets and found that the protocol not only halted the immune destruction caused by diabetes but also allowed the insulin-producing pancreatic islet cells to regenerate. Evidence indicated that the spleen cells were the sourc
'"/>




Page: 1 2

Related medicine news :

1. SARS research confirms link to animals
2. Irritable bowel syndrome associated with food intake, confirms blood test
3. Skin tests confirms cancer
4. Roche confirms Tamiflu production talks in US
5. Good news: there is no threat of bird flu confirms US
6. AIIMS medical Superintendent confirms that salary release has not been permitted
7. Creams may not reverse aging
8. Researchers reversed the process of memory loss
9. Vitamin C reverses pre eclampsia
10. Vitamin E, the latest warrior against diabetes
11. No vaccination - diabetes link

Post Your Comments:
(Date:11/20/2009)..., QUINCY, Mass., Nov. 20 Followin...rket Company removed from sale Shedd,s Country Cro... and Shedd,s Country Crock ® Side Dishes DELU...allergen. ,, The following code dates and UPCs... Side Dishes DELUXE Cheddar Broccoli Rice 21 oz, U...
(Date:11/20/2009)..., CHICAGO, Nov. 20 The... U.S. Food and Drug Administration (FDA) to establ...g chemicals. ,, Citing concern about the safet...d without the benefit of professional consultation... that the application of chemically based tooth wh...
(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNews...on a mission to redefine what it means to be "happ... counselor with a specialty in family counseling a...orest University, Gladding says research shows tha...to sadness and even depression during the holidays...
(Date:11/20/2009)...torial published online November 20 in the Journa...exaggerated fears and hopes that often appear in n...vides guidance for both the media and journals to ...M.D., M.S., and Steven Woloshin, M.D., M.S., of Ce...nstitute for Health Policy and Clinical Practice i...
(Date:11/20/2009)...le, Washington) November 20, 2009Emergency medical...ss an estimated 350,000 cardiac arrests each year....ardiac arrest survive. Better quality cardiopulmo...MS providers may be associated with better patient...ROC) is the largest clinical research network to s...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...s have found that PG-13 rated films are not safe f...tive effect on them. The PG-13 rating strongly cau...t be inappropriate for children, but the rating st... at University of California, Los Angeles (UCLA). ...
...r-old wait of the Zhimomi family living in Nagalan...fter nearly 20 years since India got its first tes...d to deliver a test tube baby. Akheli succ...gion but all in vain. They ultimately landed at th...
...a continued to reel under a scorching June sun wit...rees Celsius Friday and Sri Ganganagar in Rajastha...d that rain clouds were nowhere in sight. ...n north India are experiencing high temperatures. ...
...have a million less AIDS patients than has been wi...ased survey whose findings were reported here. ... Melinda Gates Foundation and carried out under in... An official United Nations 2006 estimated that...
... most often-used classroom approaches for teaching...ted, until now. With a $3 million federal grant, ...rsity of North Carolina at Chapel Hill will soon b...nt center, which will help states incorporate effe...
...t clear why overweight elderly adults have low lev...hers at the Jean Mayer USDA Human Nutrition Resear...) have found that lack of sun exposure may not acc...xyvitamin D, the storage form of vitamin D, compar...
Other Medicine News:Health News:PG-13 Rated Films Adversely Expose Kids to Violence 2Health News:India Has a Million Less AIDS Cases Than Believed: Study 2Health News:FPG Receives $8 Million for Autism Research 2Health News:Lack of Sun Does Not Explain Low Vitamin D in Elderly Who are Overweight 2
(Date:11/19/2009)..., MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire-Fi... ALXA ) announced today that its corporate present...Piper Jaffray Health Care Conference on Wednesday,...presentation will be webcast from The New York Pal...mas B. King, Alexza President and CEO. ,, To ...
(Date:11/19/2009)... , CAMBRIDGE, Mass., Nov. 19 L... molecule microarray technology to find drugs agai...s raised $1M in seed financing led by incTANK Vent... its initial discovery campaign that will screen o...his investment, incTANK Ventures General Partner C...
(Date:11/19/2009)... , SCHAUMBERG, Ill., Nov. 19 ...e, PACS-neutral healthcare image management soluti...nt to provide a combined PACS- neutral archive sol..., Data Distributing, an international leader in pr...olutions to the medical industry. Under the agree...
Breaking Medicine Technology:Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Research Seeks Cause of Preeclampsia 56807 1Research Seeks Cause of Preeclampsia 56807 2Heavy drinking colleges showing no improvements 56803 1Heavy drinking colleges showing no improvements 56803 2SNM applauds FDAs decision to approve Zevalin 56799 1SNM applauds FDAs decision to approve Zevalin 56799 2
...N FRANCISCO--(BUSINESS WIRE)--May 21, 2007 - Medic...growing problem of,hospital-acquired gram-negative...d-amikacin), which is a product candidate being,de...ults of a Phase 2a clinical trial evaluating the u...cally ventilated,patients with hospital-acquired g...
...LBOURNE, Australia & MENLO PARK, Calif.--(BUSI...ls (ASX: CXS, NASDAQ: CXSP) notes,the publication ...trategy for Ceflatonin(R) (homoharringtonine). The... Philadelphia-positive leukemias",by researchers S...,Bologna, Italy (Haematologica Volume 92, pages 40...
Other Medicine Technology:Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 2Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 3
CORNING STRIPETTE SEROLOGICAL PIPETTE, 5 ml
...rgeon and O.R. staff work hard to protect the pati...nual methods are complicated, time-consuming, and ...id Management System for hysteroscopy, designed by...t has been developed to provide simple, accurate, ...
Pyrex brand volumetric pipette, color-coded
Ovation BioNatural Pipette, one-stroke, fixed volume, 1000L
Medicine Products: